ARALDI; Gian Luca
Patent Applications and Registrations
Patent applications and USPTO patent grants for ARALDI; Gian Luca.The latest application filed is for "methods of treating cognitive and behavioral impairment in down syndrome and alzheimers disease patients".
Company Profile
0.29.29
- ARALDI; Gian Luca - East Setauket NY
- Araldi; Gian-Luca - East Satauket NY
- Araldi; Gian Luca - Plymouth MA
- Araldi; Gian Luca - San Diego CA
- Araldi; Gian Luca - Sedauket NY
- Araldi; Gian Luca - Setauket NY
- Araldi; Gian Luca - Smithtown NY
- Araldi; Gian Luca - Washington DC
- Araldi; Gian Luca - Quincy MA
Patent Activity
| Patent | Date |
|---|---|
| Methods Of Treating Cognitive And Behavioral Impairment In Down Syndrome And Alzheimers Disease Patients App 20180243260 - ARALDI; Gian Luca | 2018-08-30 |
| Methods Of Treating Cognitive And Behavioral Impairment In Down Syndrome And Alzheimers Disease Patients App 20180000774 - ARALDI; GIAN LUCA | 2018-01-04 |
| Phthalazine derivatives as inhibitors of protein kinase Grant 8,349,836 - Araldi , et al. January 8, 2 | 2013-01-08 |
| Pyrrolidine derivatives as prostaglandin modulators Grant 8,058,305 - Liao , et al. November 15, 2 | 2011-11-15 |
| Phthalazine derivatives as inhibitors of protein kinase Grant 8,044,041 - Araldi , et al. October 25, 2 | 2011-10-25 |
| Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders Grant 8,044,103 - Kozikowski , et al. October 25, 2 | 2011-10-25 |
| Phthalazine Derivatives App 20110237571 - Araldi; Gian-Luca ; et al. | 2011-09-29 |
| Pyridoazepine derivatives Grant 7,897,595 - Araldi , et al. March 1, 2 | 2011-03-01 |
| Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors Grant 7,863,312 - Araldi , et al. January 4, 2 | 2011-01-04 |
| Pyrrolidin-2-one derivatives for use as DP.sub.1 receptor agonists Grant 7,696,243 - Araldi April 13, 2 | 2010-04-13 |
| Pyrrolidine derivatives as prostaglandin modulators Grant 7,635,713 - Liao , et al. December 22, 2 | 2009-12-22 |
| Pyrrolidine Derivatives As Prostaglandin Modulators App 20090292000 - Liao; Yihua ; et al. | 2009-11-26 |
| Synthesis Of Heterocyclic Compounds App 20090192315 - Araldi; Gian-Luca ; et al. | 2009-07-30 |
| Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands Grant 7,563,797 - Araldi , et al. July 21, 2 | 2009-07-21 |
| Synthesis Of Heterocyclic Compounds App 20090143593 - Araldi; Gian-Luca ; et al. | 2009-06-04 |
| Synthesis of heterocyclic compounds Grant 7,511,150 - Araldi , et al. March 31, 2 | 2009-03-31 |
| Pyridoimidazole derivatives Grant 7,501,438 - Ronsheim , et al. March 10, 2 | 2009-03-10 |
| Hydrazide derivatives as prostaglandin receptors modulators Grant 7,465,755 - Araldi , et al. December 16, 2 | 2008-12-16 |
| Pyrazalidinone Compounds As Ligands Of The Prostaglandin Ep2 And/or Ep4 Receptors App 20080234346 - ARALDI; Gian Luca ; et al. | 2008-09-25 |
| Gamma lactams as prostaglandin agonists and use thereof Grant 7,419,999 - Araldi , et al. September 2, 2 | 2008-09-02 |
| Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors Grant 7,410,991 - Araldi , et al. August 12, 2 | 2008-08-12 |
| Indazole Derivatives Useful As Melanin Concentrating Receptor Ligands App 20080153810 - Ronsheim; Matthew ; et al. | 2008-06-26 |
| Phthalazine Derivatives App 20080146547 - Araldi; Gian-Luca ; et al. | 2008-06-19 |
| Pyrrolidine Derivatives As Prostaglandin Modulators App 20080114051 - LIAO; Yihua ; et al. | 2008-05-15 |
| Imidazopyridine And Imidazopyrimidine Derivatives App 20080058350 - Araldi; Gian-Luca ; et al. | 2008-03-06 |
| Pyrrolidine derivatives as prostaglandin modulators Grant 7,335,680 - Liao , et al. February 26, 2 | 2008-02-26 |
| Pyrrolidin-2-One Derivatives for Use as Dp1 Receptor Agonists App 20080027126 - Araldi; Gian Luca | 2008-01-31 |
| Synthesis Of Heterocyclic Compounds App 20080009632 - Araldi; Gian-Luca ; et al. | 2008-01-10 |
| Pyridoimidazole Derivatives App 20080009491 - Ronsheim; Matthew ; et al. | 2008-01-10 |
| Pyridoazepine Derivatives App 20070281918 - Araldi; Gian-Luca ; et al. | 2007-12-06 |
| G-lactam derivatives as prostaglandin agonists Grant 7,276,531 - Araldi , et al. October 2, 2 | 2007-10-02 |
| Hydrazide derivatives as prostaglandin receptors modulators App 20070185191 - Araldi; Gian Luca ; et al. | 2007-08-09 |
| Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders App 20070161640 - Kozikowski; Alan P. ; et al. | 2007-07-12 |
| Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders Grant 7,202,279 - Kozikowski , et al. April 10, 2 | 2007-04-10 |
| Inhibitors of serine protease activity of matriptase or MTSP1 Grant 7,157,596 - Semple , et al. January 2, 2 | 2007-01-02 |
| G-lactam derivatives as prostaglandin agonists App 20060194865 - Araldi; Gian Luca ; et al. | 2006-08-31 |
| Gamma lactams as prostaglandin agonists and use thereof App 20050288357 - Araldi, Gian Luca ; et al. | 2005-12-29 |
| Pyrrolidine derivatives as prostaglandin modulators App 20050176800 - Liao, Yihua ; et al. | 2005-08-11 |
| Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors App 20040254233 - Araldi, Gian Luca ; et al. | 2004-12-16 |
| Bicyclic metabotropic glutamate receptor ligands Grant 6,825,211 - Kozikowski , et al. November 30, 2 | 2004-11-30 |
| Analogs of cocaine Grant 6,806,281 - Kozikowski , et al. October 19, 2 | 2004-10-19 |
| Inhibitors of serine protease activity of matriptase or MTSP1 Grant 6,797,504 - Madison , et al. September 28, 2 | 2004-09-28 |
| Bicyclic metabotropic glutamate receptor ligands Grant 6,610,743 - Kozikowski , et al. August 26, 2 | 2003-08-26 |
| Monomeric and dimeric heterocycles, and therapeutic uses thereof Grant 6,605,621 - Kozikowski , et al. August 12, 2 | 2003-08-12 |
| Monomeric and dimeric heterocycles, and therapeutic uses thereof App 20030144289 - Kozikowski, Alan P. ; et al. | 2003-07-31 |
| Subtype-selective NMDA receptor ligands and the use thereof App 20030144319 - Bigge, Christopher F. ; et al. | 2003-07-31 |
| Analogs of cocaine App 20030144322 - Kozikowski, Alan P. ; et al. | 2003-07-31 |
| Inhibitors of serine protease activity of matriptase or MTSP1 App 20030050251 - Semple, Joseph E. ; et al. | 2003-03-13 |
| Substituted hydrazinyl heteroaromatic inhibitors of thrombin Grant 6,506,761 - Araldi , et al. January 14, 2 | 2003-01-14 |
| Bicyclic metabotropic glutamate receptor ligands App 20020165200 - Kozikowski, Alan P. ; et al. | 2002-11-07 |
| Analogs of cocaine Grant 6,472,422 - Kozikowski , et al. October 29, 2 | 2002-10-29 |
| Analogs of cocaine App 20020055521 - Kozikowski, Alan P. ; et al. | 2002-05-09 |
| Bicyclic metabotropic glutamate receptor ligands Grant 6,376,532 - Kozikowski , et al. April 23, 2 | 2002-04-23 |
| Tropane derivatives and method for their synthesis Grant 6,350,758 - Kozikowski , et al. February 26, 2 | 2002-02-26 |
| Subtype-selective NMDA receptor ligands and the use thereof App 20010051633 - Bigge, Christopher F. ; et al. | 2001-12-13 |
| Bicyclic metabotropic glutamate receptor ligands App 20010018429 - Kozikowski, Alan P. ; et al. | 2001-08-30 |
| Subtype-selective NMDA receptor ligands and the use thereof Grant 6,218,404 - Bigge , et al. April 17, 2 | 2001-04-17 |
| Analogs of cocaine Grant 6,180,648 - Kozikowski , et al. January 30, 2 | 2001-01-30 |
Company Registrations
| NCAGE Code | 71DM0 | ARALDI, GIAN LUCA |
| CAGE Code | 71DM0 | ARALDI, GIAN LUCA |
| S.A.M. Registration | 71DM0 [79235699] | ARALDI, GIAN LUCA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 